Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Status: Opinion
Human medicines European public assessment report (EPAR): Liraglutide STADA, liraglutide, Status: Opinion
Human medicines European public assessment report (EPAR): Orblid, bevacizumab, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Veblocema, infliximab, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Etcamah, camizestrant, Status: Opinion
Summary of opinion: Trodelvy, 21/05/2026 Positive
Summary of opinion: Maviret, 21/05/2026 Positive
Summary of opinion: Sogroya, 21/05/2026 Positive
Summary of opinion: Palynziq, 21/05/2026 Positive